AKT1 and lung adenocarcinoma: Based on the findings, we first discovered that HNF4G promotes MAPK6 expression and subsequent Akt phosphorylation by binding to the MAPK6 promoter region, resulting in cisplatin resistance in lung adenocarcinoma.